Recent Press Releases

BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial
Jan. 3, 2013
 
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter Into Agreement to Combine Businesses
Nov. 19, 2012
 
BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results
Nov. 5, 2012
 
BioMimetic Therapeutics, Inc. Reports Second Quarter 2012 Earnings Results
Aug. 2, 2012
 
BioMimetic Therapeutics, Inc. to Report Second Quarter 2012 Financial Results on August 2
Aug. 1, 2012
 
BioMimetic Therapeutics Submits Augment® Bone Graft PMA Amendment to FDA
July 9, 2012
 
Timothy Daniels, MD Presents Results from Augment™ Injectable Bone Graft Clinical Trial
June 25, 2012
 
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and Ankle Society Meeting
June 20, 2012
 
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and Ankle Society Meeting
June 20, 2012
 
BioMimetic Therapeutics Announces Highlights from 2012 Annual Meeting of Stockholders
June 7, 2012
 
BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results
May 9, 2012
 
BioMimetic Therapeutics, Inc. to Report First Quarter 2012 Financial Results on May 9
May 7, 2012
 
BioMimetic Therapeutics, Inc. Reports Fourth Quarter and Year-End 2011 Earnings Results
March 13, 2012
 
BioMimetic Therapeutics, Inc. to Introduce Augmatrix™ Biocomposite Bone Graft Product Line at AAOS
Feb. 8, 2012
 
BioMimetic Therapeutics, Inc. to Highlight Product Development Activities at ORS and AAOS Meetings Company Announces Results of its Augment® Rotator Cuff Graft Clinical Trial
Feb. 6, 2012
 
BioMimetic To Present at 30th Annual J.P. Morgan Healthcare Conference
Jan. 10, 2012
 
BioMimetic Therapeutics, Inc. to Present at the J.P Morgan Healthcare Conference
Jan. 5, 2012
 
BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter from FDA
Jan. 3, 2012
 
BioMimetic Receives PMA Post Panel Response Letter
Jan. 3, 2012
 
BioMimetic Therapeutics Announces Approval to Market GEM 21S® in the European Union
Jan. 3, 2012
 

2013 2012 2011 2010 2009 2008 2007 2006 2005